BOSTON — In this Healio Video Perspective from the ASCRS meeting, Richard L. Lindstrom, MD, overviews two dry eye products from Surface Ophthalmics.
One is an over-the-counter artificial tear targeted for surgery-associated dry eye syndrome, and the other is a mycophenolate-based immunosuppressive indicated for mild to moderate dry eye, with positive results seen in a phase 2 trial.